Meluzio Michael Vincent insider trades

Meluzio Michael Vincent has filed 3 Form 4s with the SEC that we hold, all for Cue Biopharma, Inc. (CUE), as VP, Prin. Accounting Officer. Across all of them we count 0 purchases worth $0 and 4 sales worth $201.4K reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($201.4K). The largest single trade was a sale of 4,106 shares of Cue Biopharma, Inc. worth $124.6K, dated 2026-08-13. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2026-07-10 and the latest 2026-10-14.

Cue Biopharma, Inc. (CUE)

VP, Prin. Accounting Officer · 3 filings · 4 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2026-08-13	S, sale reported on Form 4	1,519	$44.6K	2026-08-17	SEC
2026-08-13	S, sale reported on Form 4	4,106	$124.6K	2026-08-17	SEC
2026-08-13	S, sale reported on Form 4	3	$93	2026-08-17	SEC
2026-10-12	S, sale reported on Form 4	1,144	$32.1K	2026-10-14	SEC

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 2138368) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms